These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21629912)

  • 1. Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration.
    Bhuyan BJ; Mugesh G
    Org Biomol Chem; 2011 Jul; 9(14):5185-92. PubMed ID: 21629912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant activity of peptide-based angiotensin converting enzyme inhibitors.
    Bhuyan BJ; Mugesh G
    Org Biomol Chem; 2012 Mar; 10(11):2237-47. PubMed ID: 22307539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme.
    Dalkas GA; Marchand D; Galleyrand JC; Martinez J; Spyroulias GA; Cordopatis P; Cavelier F
    J Pept Sci; 2010 Feb; 16(2):91-7. PubMed ID: 20014331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
    Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
    Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of new peptide inhibitors on the ratio of angiotensin I-converting and kinin-degrading activities of dipeptidyl carboxypeptidase (angiotensin-converting enzyme).
    Kalinina EV; Posdnev VF; Komissarova NV; Gomazkov OA
    Biochemistry (Mosc); 1997 Mar; 62(3):247-50. PubMed ID: 9275297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase.
    Fink CA; Carlson JE; McTaggart PA; Qiao Y; Webb R; Chatelain R; Jeng AY; Trapani AJ
    J Med Chem; 1996 Aug; 39(16):3158-68. PubMed ID: 8759637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence.
    Guy JL; Jackson RM; Acharya KR; Sturrock ED; Hooper NM; Turner AJ
    Biochemistry; 2003 Nov; 42(45):13185-92. PubMed ID: 14609329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic determination of the binding constants of angiotensin-converting enzyme inhibitors by a displacement method.
    Andújar-Sánchez M; Jara-Pérez V; Cámara-Artigas A
    FEBS Lett; 2007 Jul; 581(18):3449-54. PubMed ID: 17618628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silanediol peptidomimetics. Evaluation of four diastereomeric ACE inhibitors.
    Kim J; Sieburth SM
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2853-6. PubMed ID: 15125946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC; Pullen MA; Edwards RM; Brooks DP
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1141-7. PubMed ID: 14769834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxyl-terminal tripeptidyl hydrolysis of substance P by purified rabbit lung angiotensin-converting enzyme and the potentiation of substance P activity in vivo by captopril and MK-422.
    Cascieri MA; Bull HG; Mumford RA; Patchett AA; Thornberry NA; Liang T
    Mol Pharmacol; 1984 Mar; 25(2):287-93. PubMed ID: 6199659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silanediol inhibitors of angiotensin-converting enzyme. Synthesis and evaluation of four diastereomers of Phe[Si]Ala dipeptide analogues.
    Kim J; Hewitt G; Carroll P; Sieburth SM
    J Org Chem; 2005 Jul; 70(15):5781-9. PubMed ID: 16018669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
    Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
    Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular basis for the selection of captopril cis and trans conformations by angiotensin I converting enzyme.
    Tzakos AG; Naqvi N; Comporozos K; Pierattelli R; Theodorou V; Husain A; Gerothanassis IP
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5084-7. PubMed ID: 16889963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proline rich-oligopeptides: diverse mechanisms for antihypertensive action.
    Morais KL; Ianzer D; Miranda JR; Melo RL; Guerreiro JR; Santos RA; Ulrich H; Lameu C
    Peptides; 2013 Oct; 48():124-33. PubMed ID: 23933300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.